---
title: "SINOPHARM's subsidiary SINOPHARM(CNCM LTD) earned 1.997 billion RMB for the year, a slight decrease of 0.2%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279821917.md"
description: "SINOPHARM announced that its subsidiary SINOPHARM(CNCM LTD) achieved an operating revenue of 52.468 billion RMB for the fiscal year 2025, an increase of 3.7% year-on-year. The net profit attributable to shareholders was 1.997 billion RMB, a slight decrease of 0.2%, with earnings per share of 2.6462 RMB"
datetime: "2026-03-19T16:04:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279821917.md)
  - [en](https://longbridge.com/en/news/279821917.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279821917.md)
---

# SINOPHARM's subsidiary SINOPHARM(CNCM LTD) earned 1.997 billion RMB for the year, a slight decrease of 0.2%

SINOPHARM (01099.HK) announced that its subsidiary SINOPHARM(CNCM LTD) (600511.SH) achieved an operating revenue of RMB 52.468 billion for the fiscal year 2025, an increase of 3.7% year-on-year. The net profit attributable to shareholders was RMB 1.997 billion, a slight decrease of 0.2%, with earnings per share of RMB 2.6462

### Related Stocks

- [000028.CN](https://longbridge.com/en/quote/000028.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [589720.CN](https://longbridge.com/en/quote/589720.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [159929.CN](https://longbridge.com/en/quote/159929.CN.md)
- [01099.HK](https://longbridge.com/en/quote/01099.HK.md)
- [600511.CN](https://longbridge.com/en/quote/600511.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)

## Related News & Research

- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Everest Medicines Director and Major Shareholder Raises Stake in Company](https://longbridge.com/en/news/286481551.md)
- [Manulife Singapore to offer multi-cancer blood test starting May](https://longbridge.com/en/news/286710691.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)